Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0519-2019Class II

Dash 3000 Patient Monitoring System is used to monitor physiologic parameter data on adult, pediatric and...

GE Healthcare / initiated 2018-08-31 / Open, Classified / root cause: software

GE Healthcare, LLC began a recall of Dash 3000 Patient Monitoring System is used to monitor physiologic parameter data on adult, pediatric and neonatal patients on . FDA classified it as Class II and gives the reason as "The patient monitors may simultaneously restart as designed if all are connected to the same network and a network overload occurs for a prolonged time". As of , the recall status on record is Open, Classified, and MDM tags the root cause as software.

Recall record

Recall number
Z-0519-2019
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
GE Healthcare
Product
Dash 3000 Patient Monitoring System is used to monitor physiologic parameter data on adult, pediatric and neonatal patients.
Product code
MHZ Stimulator, Vestibular Acceleration, Therapeutic
Reason for recall
The patient monitors may simultaneously restart as designed if all are connected to the same network and a network overload occurs for a prolonged time.
Root cause tag
software
FDA root cause
Software design
Action
The recalling firm issued letters dated 8/31/2018 via FedEx on 8/31/2018 informing the customer of the issue and providing safety instructions for mitigation of the issue if a prolonged network overload occurs and the Dash and/or Solar patient monitor on the network does not resume normal functionality in approximately 90 seconds.
Quantity in commerce
Approximately 182,640 monitoring systems for Dash 3000/4000/5000
Distribution
Distribution was made nationwide, including Puerto Rico, Guam, and Samoa. There was also government and military distribution. Foreign distribution was made to Canada, Algeria, Angola, Argentina, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Belarus, Belgium, Bermuda, Bolivia, Bosnia and Herzegovina, Brazil, Brunei Darussalam, Bulgaria, Cambodia, Cameroon, Chile, China, Colombia, Costa Rica, Cota D'Ivoire, Croatia, Cyprus, Czech Republic, Denmark, Djibouti, Dominican Republic, Ecuadore, Egypt, El Salvador, Estonia, Ethiopia, Finland, France, French Guiana, Gabon, Georgia, Germany, Ghana, Greece, Guatemala, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Korea (Republic of), Kuwait, Kyrgyzstan, Latvia, Lebanon, Libya, Lithuania, Macedonia, Malaysia, Malta, Martinique, Mauritius, Mexico, Moldova, Morocco, Namibia, Nepal, Netherlands, New Zealand, Nicaragua, Nigeria, Norway, Oman, Pakistan, Palestine, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Republic of Serbia, Reunion, Romania, Russia, Saint Lucia, Saudi Arabia, Senegal, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sudan, Sweden, Switzerland, Syria, Taiwan, Tajikistan, Tanzania, Thailand, Trinidad, Tunisia, Turkey, Turkmenistan, Uganda, Ukraine, United Arab Emirates, United Kingdom, Uruguay, Uzbekistan, Venezuela, Viet Nam, Yemen, Yugoslavia, and Zimbabwe.
Product codes and lots
All monitors

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0519-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0519-2019Class IIOngoingVoluntary: Firm initiated
Z-0520-2019Class IIOngoingVoluntary: Firm initiated
Z-0521-2019Class IIOngoingVoluntary: Firm initiated
Z-0522-2019Class IIOngoingVoluntary: Firm initiated
Z-0523-2019Class IIOngoingVoluntary: Firm initiated
Z-0524-2019Class IIOngoingVoluntary: Firm initiated